SJ 01
Alternative Names: SJ-01Latest Information Update: 23 Mar 2022
At a glance
- Originator Shanghai Bao Pharmaceuticals
- Class Antianaemics; Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Anaemia
Most Recent Events
- 15 Mar 2022 Phase-III clinical trials in Anaemia in China (Parenteral) (Shanghai Bao Pharmaceutical pipeline, March 2022)